Cigna + Oscar
Lynparza (olaparib)
Drugs for Cancer : Drugs for Cancer
  • Step Therapy: ST Multiple Generics

  • Prior Authorization: PA_APPLIES
  • Idiopathic Hypersomnia:
    Age Requirement: >= 18
    Duration: 3 Month(s)
    Documented Diagnosis: Yes
    Medical Test Required: Yes
    Reauthorization Required: Yes
    Duration of Reauthorization: = 6 month(s)

    Narcolepsy Type 1, Narcolepsy Type 2:
    Age Requirement: >= 7
    Duration: 3 Month(s)
    Documented Diagnosis: Yes
    Medical Test Required: Yes
    Reauthorization Required: Yes
    Duration of Reauthorization: = 6 month(s)

    Neurology: Narcolepsy:
    Age Requirement: >= 7
    Duration: 3 Month(s)
    Medical Test Required: Yes
    Reauthorization Required: Yes
    Duration of Reauthorization: = 6 month(s)
    Number of Episodes of Cataplexy Required in Policy: > 1
    Documented Duration of Daily EDS Occurrences: >= 3 month(s)
    Policy Criteria Required to Document Patient Multiple Sleep Latency Test (MSLT): 1 of MSLT =< 8 min with evidence of >=2 SOREMPs;MSLT with evidence of >= 1 SOREMP's and SOREMP, 15 min from preceding night polysomnography (PSG)
    Other causes of sleepiness have been ruled out.: No
    Patient must have CSF hypocretin 1 deficiency: Yes
    Patient Does Not Have a Deficiency of Succinic Semialdehyde Dehydrogenase: Yes
    Patient Does Not Have a History of Substance Abuse: No
    Patient is Not Using a Sedative Hypnotic: Yes
    Patient Will Not Be Using with Alcohol: Yes
    Documentation Requiring Patient to be Enrolled in REMS Success Program: No
    Documentation of prescriber enrollment in REMS program: No
    Prescriber Must Check Patient's Drug History on Controlled Substance Database: No
    Documented Time Period or Frequency of Time That the Precriber Must Regularly See the Patient: N/A
    Diagnosis Type(s): 1 of Narcolepsy Type 1 (with Cataplexy);Narcolepsy Type 2 (without Cataplexy)
    Supporting Documentation Requirements: 2 of Chart Notes;Medical Tests;Medication History
    Documented Diagnosis: Yes
    Patient has >1 Cataplexy Episodes: Yes
    Documented Daily EDS occurrences >= 3 months: Yes
    MSLT <8min with evidence of 2 SOREMP's: No
    MSLT with evidence of >= 1 SOREMP's and SOREMP, 15 min from preceeding night PSG: Yes
    CSF Hypocretin-1 Deficiency: Yes
    Prescriber Must See Patient Every 3 Months: No

  • Preferred agent for Psoriasis and Psoriatic Arthritis